Ring 1
Ring 2
Ring 3
Ring 4

Neurona Therapeutics

Financing Rounds

  • Series B
  • Series C
Round Led by Symbiosis
Round Led by Symbiosis

Neurona has built a robust regenerative platform based on a novel neural cell lineage developed by the company’s scientific founders, and is developing off-the-shelf, allogeneic neuronal, glial, and gene edited cell therapy candidates that provide long-term integration and repair of dysfunctional neural networks for multiple neurological disorders. Neurona’s cell therapies have single-dose curative potential.

View Website


  • Cell Therapy


  • Neurology

Development Status

  • Phase 1